Literature DB >> 3040390

Activation of sodium transport in human erythrocytes by beta-adrenoceptor stimulation in vivo.

H H Bodemann, M Irmer, K J Schlüter, M Reininghaus, J Keul.   

Abstract

Beta-adrenoceptor stimulation in vivo shifts potassium into the cells. To examine whether human erythrocytes participate in this process, we measured, along with serum or plasma potassium, the concentrations of potassium and sodium in erythrocytes. Beta-adrenoceptor stimulation was obtained by infusion of either fenoterol or hexoprenaline into 6 volunteers at rest or by endogenous amines provoked in 14 volunteers during ergometric exercise. Metabolic effects were followed at rest on serum insulin, C-peptide, and growth hormone levels, and during exercise on pH on lactate concentration in blood. The potassium concentration (mean +/- S.E.M.) dropped (p less than 0.01) in serum from 4.64 +/- 0.37 to 3.19 +/- 0.43 mmol x l-1 in the first hour at rest and in plasma from 5.70 +/- 0.93 to 4.63 +/- 0.45 in 90 sec directly after exercise. The concentration of erythrocyte sodium dropped (p less than 0.001) from 9.68 +/- 0.73 to 8.81 +/- 0.62 mmol x l-1 in cells and from 9.62 +/- 1.16 to 8.55 +/- 1.24 during exercise for 90 s, respectively. Changes in the concentration ratio of cellular sodium to potassium confirmed this sodium shift. An increased sodium transport in erythrocytes due to beta-adrenoceptor stimulation in vivo appears to complement a shift of serum potassium into the cells and may be mediated by the membrane-bound sodium, potassium ATPase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040390     DOI: 10.1007/BF00417762

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  18 in total

1.  The linkage of sodium, potassium, and ammonium active transport across the human erythrocyte membrane.

Authors:  R L POST; P C JOLLY
Journal:  Biochim Biophys Acta       Date:  1957-07

2.  The action of adrenaline on serum potassium.

Authors:  J L D'Silva
Journal:  J Physiol       Date:  1934-11-12       Impact factor: 5.182

3.  Blood levels of adrenergic amines during exercise.

Authors:  E W Banister; J Griffiths
Journal:  J Appl Physiol       Date:  1972-11       Impact factor: 3.531

4.  Kalemotropic effect of epinephrine: analysis with adrenergic agonists and antagonists.

Authors:  E P Todd; R L Vick
Journal:  Am J Physiol       Date:  1971-06

5.  Disappearance of norepinephrine from the circulation following strenuous exercise.

Authors:  J M Hagberg; R C Hickson; J A McLane; A A Ehsani; W W Winder
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-12

6.  The difference between serum and plasma potassium.

Authors:  D Hyman; N M Kaplan
Journal:  N Engl J Med       Date:  1985-09-05       Impact factor: 91.245

7.  Ouabain-uninhibited sodium transport in human erythrocytes. Evidence against a second pump.

Authors:  M J Dunn
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  [Plasma dopamine, noradrenaline and adrenaline response during cardiac and peripheral-muscular exhaustion].

Authors:  M Lehmann; R Kapp; U Spöri; J Keul
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

9.  Inhibition of the Na+/K+ cotransport system by cyclic AMP and intracellular Ca2+ in human red cells.

Authors:  R P Garay; J Ciccone
Journal:  Biochim Biophys Acta       Date:  1982-06-28

10.  Indices of cardiac function during treatment with betamimetic drugs (fenoterol and hexoprenaline).

Authors:  U Siekmann; L Heilmann; M Irmer
Journal:  Arch Gynecol       Date:  1983
View more
  2 in total

Review 1.  Exercise, training and red blood cell turnover.

Authors:  J A Smith
Journal:  Sports Med       Date:  1995-01       Impact factor: 11.136

2.  Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry.

Authors:  B Fagher; H Liedholm; M Monti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.